Author Archives: Natalie Themm
BioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome
ReNU syndrome was discovered in 2024 and there are no medicines approved for the condition.
CancerVax Develops Novel Smart mRNA to Harness Pre-Existing Immunity in 99% of World Population
Company completes design and in-vitro validation of a single Smart mRNA that disguises cancer as multiple viral infections simultaneously to activate pre-existing T-cell immunity.
Halia Therapeutics Presents Two AAIC 2026 Posters on HT-4253 for Alzheimer’s Prevention in APOE4 Carriers
Preclinical data show HT-4253 reduces neuroinflammation and tau pathology; a second details a Phase 2a biomarker trial in pre-symptomatic APOE4 carriers via UAE genomics.
SINTX Secures $3.2M Advanced Ceramic Component Orders
Purchase orders from multiple contract manufacturing customers have a combined value of more than $3.2M.
Renew Labs Receives Accreditation from the College of American Pathologists
CAP accreditation is widely recognized as a mark of laboratory quality and operational excellence.
Renew Biotechnologies Unifies Wasatch BioLabs and Resonant Under One Brand to Advance Sequencing-Based Diagnostics
Brand consolidation strengthens Renew’s ability to move advanced molecular technologies from discovery to clinical implementation.
U of U Startup Advances MRI Accessibility Amid New Federal Requirements
KyphoLift is gaining attention as hospitals and imaging centers prepare for federal accessibility requirements.
Merit Medical Ribbon Cutting & Facility Tour
Marks an important milestone with a ribbon-cutting ceremony celebrating the completion of an expansive new distribution center.
GPX® Embolic Device meets Primary Endpoints in IDE Pivotal Trial
Trial Reports 99% Successful Occlusion of Flow with 40 Investigators Delivering the New Embolic Through 20 Different Catheters.
Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand
Workshop brings together national TB programs, researchers, donors, and technical agencies from 21 countries to advance implementation of WHO-recommended near-point-of-care diagnostics.
FDA Accepts sNDA for Roflumilast Cream 0.05% in Infants With Atopic Dermatitis Down to 3 Months
INTEGUMENT-INFANT showed 49.1% achieving vIGA-AD clear/almost clear at week 4 and 27.3% meeting vIGA-AD Success, alongside rapid pruritus improvement.
Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain Barrier
resentation will highlight recent scientific advances and future opportunities to accelerate discovery and development of medicines for neurodegenerative diseases.
